Showing results (1431-1440 of 1,587) with videos related to
Sort By:
Pageof 159
Journal of Perinatology : Official Journal of the California Perinatal Association|April 16, 2024
A clinical consensus guideline for nutrition in infants with congenital diaphragmatic hernia from birth through dischargePatrick Sloan, Sandy Johng, John M Daniel, et al.Breast Cancer Research : BCR|July 3, 2016
Genome co-amplification upregulates a mitotic gene network activity that predicts outcome and response to mitotic protein inhibitors in breast cancerZhi Hu, Jian-Hua Mao, Christina Curtis, et al.Cancer Research|January 17, 2009
Basal subtype and MAPK/ERK kinase (MEK)-phosphoinositide 3-kinase feedback signaling determine susceptibility of breast cancer cells to MEK inhibitionOlga K Mirzoeva, Debopriya Das, Laura M Heiser, et al.Proceedings of the National Academy of Sciences of the United States of America|July 22, 1998
Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinomaC Collins, J M Rommens, D Kowbel, et al.Cancer Cell|December 13, 2006
A collection of breast cancer cell lines for the study of functionally distinct cancer subtypesRichard M Neve, Koei Chin, Jane Fridlyand, et al.NPJ Precision Oncology|October 20, 2021
Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapiesMarilyne Labrie, Allen Li, Allison Creason, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 29, 2009
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinomaLee W T Alkureishi, Zeynep Burak, Julio A Alvarez, et al.Annals of Surgical Oncology|October 2, 2009
Joint practice guidelines for radionuclide lymphoscintigraphy for sentinel node localization in oral/oropharyngeal squamous cell carcinomaL W T Alkureishi, Z Burak, J A Alvarez, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657Laura J Esserman, Donald A Berry, Angela DeMichele, et al.Cancer Research|May 14, 2009
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristicsBryan T Hennessy, Ana-Maria Gonzalez-Angulo, Katherine Stemke-Hale, et al.Pageof 159